Arca
Skip to content
Tools
Tools

CARA (Computer Assisted Retinal Analysis)

Recall Z-0826-2022, part of FDA recall event 89715. See Diagnos's company page.

Diagnos Inc started this Class II device recall on Jan 11, 2022 (voluntary: firm initiated); FDA lists it as terminated, terminated Jun 18, 2024.

  • Classification: Class II
  • Started: Jan 11, 2022
  • Status: Terminated

Why It Was Recalled

Class II

Retinal analysis system software has some features, based on artificial intelligence, that potentially lack appropriate market approval, so it is recommended to use a specific prior software version.

Record

Product
CARA (Computer Assisted Retinal Analysis), Product ID: +B543CARA0/$$+7V4.7.2/16D202111179
Quantity
1
Lots and codes
Software Version 4.7.2
Distribution
US: CA
Recalling firm
Diagnos Inc, Brossard, N/A, Canada
How the firm notified
Letter
FDA classified
Mar 25, 2022

FDA's weekly Enforcement Report, as openFDA publishes it. A recall is classified by how likely the product is to cause harm: Class I is the most serious. openFDA device enforcement reports

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.